Horn Howard

Horn Howard is listed in filings as Chief Financial Officer at Ultragenyx Pharmaceutical Inc. This profile follows SEC Form 4 activity through Jun 1, 2026, including sale activity. Recent filings connect the profile to Ultragenyx Pharmaceutical Inc (RARE). The current snapshot covers public activity from Oct 11, 2024 to Jun 1, 2026. Reported amounts are shown as $110.6K to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.